Schrodinger, Inc. Common Stock
SDGR US80810D1037
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -56% | -47% | 96% | -45% | 2% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Akinsanya Karen PR |
25.11 USD |
8,378 Sold |
210,391 USD |
14/04/2025 | 14/04/2025 |
| Akinsanya Karen PR |
25.11 USD |
5,000 Sold |
125,555 USD |
14/04/2025 | 14/04/2025 |
| Akinsanya Karen PR |
25.00 USD |
3,345 Sold |
83,625 USD |
14/04/2025 | 14/04/2025 |
| Herman Jenny SR VP |
21.11 USD |
666 Sold |
14,059 USD |
06/03/2025 | 06/03/2025 |
| Porges Geoffrey Craig EX VP |
21.76 USD |
5,491 Sold |
119,484 USD |
03/03/2025 | 03/03/2025 |
| Tran Yvonne EX VP |
28.00 USD |
3,902 Sold |
109,256 USD |
18/02/2025 | 18/02/2025 |
| Tran Yvonne EX VP |
24.43 USD |
828 Sold |
20,228 USD |
11/02/2025 | 11/02/2025 |
| Herman Jenny SR VP |
24.43 USD |
859 Sold |
20,985 USD |
11/02/2025 | 11/02/2025 |
| Lorton Kenneth Patrick EX VP |
24.43 USD |
985 Sold |
24,064 USD |
11/02/2025 | 11/02/2025 |
| Abel Robert Lorne O |
25.99 USD |
1,225 Sold |
31,838 USD |
10/02/2025 | 10/02/2025 |